Haart improves prognosis in HIV-associated progressive multifocal leukoencephalopathy

Neurology

Volumn 52, Issue 3, 1999, Pages 623-625

  Clifford, David B ^a,l   Yiannoutsos, C ^b   Glicksman, M ^a   Simpson, D M ^c   Singer, E J ^d   Piliero, P J ^e   Marra, C M ^f   Francis, G S ^g   McArthur, J C ^h   Tyler, K L ⁱ   Tselis, A C ^j   Hyslop, N E ^k  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

^j WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Neurology ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; PROTEINASE INHIBITOR; RECOMBINANT ALPHA INTERFERON; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AIDS RELATED COMPLEX; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0033017386     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.3.623     Document Type: Article

References (10)

1. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998;4:59-68.
2. Hall CD, Dafni U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 1998; 338:1345-1351.
3. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338: 853-860.
4. Henry K, Worley J, Sullivan C, Stawarz K, McCabe K. Documented improvement in late stage manifestations of AIDS after starting ritonavir in combination with two reverse transcriptase inhibitors. Fourth Conference on Retroviruses and Opportunistic Infections; Washington, DC; January 22-26, 1997;356:130. Abstract.
5. Milano MD, Tashima K, Farrar D, Elliot BC, Rich JD, Flanigan TP. Resolution of AIDS related opportunistic infections with addition of protease inhibitor treatment. Fourth Conference on Retroviruses and Opportunistic Infections; Washington, DC; January 22-26, 1997;355:129. Abstract.
6. Miralles P, Padilla B, Berenguer J, et al. Therapy of AIDS-associated progressive multifocal leukoencephalopathy with protease inhibitors combination regimens. Fifth Retrovirus and Opportunistic Infection Conference; Chicago, IL; February 1-5, 1998;464:166. Abstract.
7. Albrecht H, Hoffmann C, Degen O, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998;12:1149-1154.
8. Gasnault J, Taoufik Y, Kousignian P, Goujard C, Dussaix E, Delfraissy JF. Effects of protease inhibitors on neurological course in AIDS-Progressive multifocal leukoencephalopathy. J Neurovirol 1998;4:351.
9. Cinque P, Casari S, Bertelli D. Progressive multifocal leukoencephalopathy, HIV and highly active antiretroviral therapy. N Engl J Med 1998;339:848-849.
10. Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 1998;44:341-349.